Early predictive factors of failure in autologous CAR T-cell manufacturing and/or efficacy in hematologic malignancies

Chimeric antigen receptor (CAR) T-cell therapies have shown significant benefits in the treatment of hematologic malignancies, such as B-cell acute lymphoblastic leukemia (B-ALL) and B-cell lymphoma. Despite the therapeutic advances offered by these innovative treatments, failures are still observed...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood advances 2024-01, Vol.8 (2), p.337-342
Hauptverfasser:	Baguet, Clémentine, Larghero, Jérôme, Mebarki, Miryam
Format:	Artikel
Sprache:	eng
Schlagworte:	Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!